8 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag... Read more
Laurent Fischer
Active Motif
3 followers
Generation Bio
2 followers
Embark Veterinary
1 follower
Ardelyx
3 followers
Asklepios BioPharmaceutical
1 follower
Thermo Fisher Scientific
174 followers
Gilead Sciences
133 followers
Neuralink
62 followers
Alexion Pharmaceuticals
34 followers
GRAIL
27 followers
BeiGene
24 followers
Explore companies